Augmented inhibitory effect of superoxide dismutase on superoxide anion release from macrophages by chemical modification with polysaccharide and attenuation effects on radiation-induced inflammatory cytokine expression in vitro

Journal of Drug Targeting

Volumn 17, Issue 3, 2009, Pages 216-224

  Liu, Jinfeng ^a   Teng, Li ^a   Liu, Chunhui ^a   Hu, Likuan ^b   Wang, Yonggang ^b   Liu, Hong ^b   Wang, Fengshan ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Anionic polysaccharide; Cationic polysaccharide; Chemical modification; Chitosan; Heparin; Superoxide dismutase

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; HEPARIN; INTERLEUKIN 1BETA; N,N,N TRIMETHYL CHITOSAN CHLORIDE; POLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; CHITOSAN; DRUG CARRIER; N TRIMETHYL CHITOSAN CHLORIDE; N-TRIMETHYL CHITOSAN CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG BINDING; DRUG SYNTHESIS; DRUG UPTAKE; ENZYME INHIBITION; IN VITRO STUDY; INFLAMMATORY DISEASE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION; ANIMAL; CELL CULTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; ENZYMOLOGY; FIBROBLAST; METABOLISM; METHODOLOGY; RADIATION EXPOSURE; SYNTHESIS;

ANIMALS; CELLS, CULTURED; CHITOSAN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FIBROBLASTS; HEPARIN; INTERLEUKIN-1BETA; MACROPHAGES; MALE; MICE; SUPEROXIDE DISMUTASE; SUPEROXIDES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 70149121526     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860802669249     Document Type: Article

References (45)

1. Abe W, Ikejima K, Lang T, Okumura K, Enomoto N, Kitamura T, Takei Y, Sato N. (2007). Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat. J Hepatol, 46, 286-294.
2. Adachi T, Hara H, Yamada H, Yamazaki N, Yamamoto M, Sugiyama T, Futenma A, Katagiri Y. (2001). Heparin-stimulated expression of extracellular-superoxide dismutase in human fibroblasts. Atherosclerosis, 159, 307-312. (Pubitemid 33127244)
3. Anraku M, Kabashima M, Namura H, Maruyama T, Otagiri M, Gebicki JM, Furutani N, Tomida H. (2008). Antioxidant protection of human serum albumin by chitosan. Int J Biol Macromol, 43, 159-164.
4. Asselot-Chapel C, Combacau L, Labat-Robert J, Kern P. (1995). Expression of fibronectin and interstitial collagen genes in smooth muscle cells: Modulation by low molecular weight heparin fragments and serum. Biochem Pharmacol, 49, 653-659.
5. Castellot JJ Jr., Wong K, Herman B, Hoover RL, Albertini DF, Wright TC, Caleb BL, Karnovsky MJ. (1985). Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol, 124, 13-20.
6. Cuzzocrea S, Thiemermann C, Salvemini D. (2004). Potential therapeutic effect of antioxidant therapy in shock and inflammation. Curr Med Chem, 11, 1147-1162.
7. Dai G, Chen Y, Gu F, Chen R. (2005). Effects of electroacupuncture on the contents of NO, ET and T-AOC in the brain tissues of the cerebral hemorrhage model rats. J Tradit Chin Med, 25, 62-65.
8. Fujita T, Furitsu H, Nishikawa M, Takakura Y, Sezaki H, Hashida M. (1992). Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusion. Biochem Biophys Res Commun, 189, 191-196.
9. Habeeb AF. (1966). Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem, 14, 328-336.
10. Hagimoto N, Kuwano K, Inoshima I, Yoshimi M, Nakamura N, Fujita M, Maeyama T, Hara N. (2002). TGF-beta1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J Immunol, 168, 6470-6478.
11. Han Y, Zhao L, Yu Z, Feng J, Yu Q. (2005). Role of mannose receptor in oligochitosan-mediated stimulation of macrophage function. Int Immunopharmacol, 5, 1533-1542.
12. Il'in LA, Andrianova IE, Glushkov VA, Bannikova GE, Varlamov VP. (2004). Medical-prophylactic properties of the low-molecularweight chitosan at environmental radiation injury. Radiat Biol Radioecol, 44, 547-549.
13. Ishimoto N, Nemoto T, Nagayoshi K, Yamashita F, Hashida M. (2006). Improved anti-oxidant activity of superoxide dismutase by direct chemical modification. J Control Release, 111, 204-211.
14. Jeon TI, Hwang SG, Park NG, Jung YR, Shin SI, Choi SD, Park DK. (2003). Antioxidative effect of chitosan on chronic carbon tetrachloride induced hepatic injury in rats. Toxicology, 187, 67-73.
15. Ji X, Zhong Z, Chen X, Xing R, Liu S, Wang L, Li P. (2007). Preparation of 1,3,5-thiadiazine-2-thione derivatives of chitosan and their potential antioxidant activity in vitro. Bioorg Med Chem Lett, 17, 4275-4279. (Pubitemid 47021383)
16. Jintapattanakit A, Mao S, Kissel T, Junyaprasert VB. (2008). Physicochemical properties and biocompatibility of N-trimethyl chitosan: Effect of quaternization and dimethylation. Eur J Pharm Biopharm, 70(2), 563-571.
17. Kinnula VL, Crapo JD. (2003). Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med, 167, 1600-1619.
18. Lee S, Murthy N. (2007). Targeted delivery of catalase and superoxide dismutase to macrophages using folate. Biochem Biophys Res Commun, 360, 275-279.
19. Lin SY, Chan HY, Shen FH, Chen MH, Wang YJ, Yu CK. (2007). Chitosan prevents the development of AOM-induced aberrant crypt foci in mice and suppressed the proliferation of AGS cells by inhibiting DNA synthesis. J Cell Biochem, 100, 1573-1580.
20. Liu JF, Wang X, Wang FS, Teng L, Cao JC. (2008). Attenuation effects of heparin-superoxide dismutase conjugate on bleomycininduced lung fibrosis in vivo and radiation-induced inflammatory cytokine expression in vitro. Biomed Pharmacother, doi:10.1016/j.biopha.2008.04.009.
21. Ma SF, Nishikawa M, Katsumi H, Yamashita F, Hashida M.(2006). Liver targeting of catalase by cationization for prevention of acute liver failure in mice. J Control Release, 110, 273-282.
22. Mihara K, Oka Y, Sawai K, Takakura Y, Hashida M. (1994). Improvement of therapeutic effect of human recombinant superoxide dismutase on ischemic acute renal failure in the rat via cationization and conjugation with polyethylene glycol. J Drug Target, 2, 317-321.
23. Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. (2008). The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol, 40, 362-382.
24. Nabout R, Martin M, Remy J, Robert L, Lafuma C. (1989). Heparin fragments modulate the collagen phenotype of fibroblasts from radiation-induced subcutaneous fibrosis. Exp Mol Pathol, 51, 111-122.
25. Nishimura Y, Kim HS, Ikota N, Arima H, Bom HS, Kim YH, Watanabe Y, Yukawa M, Ozawa T. (2003). Radioprotective effect of chitosan in sub-lethally X-ray irradiated mice. J Radiat Res (Tokyo), l44(1), 53-58.
26. Nishimura Y, Kim HS, Ikota N, Arima H, Bom HS, Kim YH, Watanabe Y, Yukawa M, Opanasopit P, Nishikawa M, Hashida M. (2002). Factors affecting drug and gene delivery: Effects of interaction with blood components. Crit Rev Ther Drug Carr Syst, 19, 191-233.
27. Opanasopit P, Nishikawa M, Hashida M. (2002). Factors affecting drug and gene delivery: Effects of interaction with blood components. Crit Rev Ther Drug Carrier Syst, 19(3), 191-233.
28. Ozawa T. (2003). Radioprotective effect of chitosan in sub-lethally X-ray irradiated mice. J Radiat Res, 44, 53-58.
29. Polnok A, Borchard G, Verhoef JC, Sarisuta N, Junginger HE. (2004). Influence of methylation process on the degree of quaternization of N-trimethyl chitosan chloride. Eur J Pharm Biopharm, 57, 77-83.
30. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN. (1995). A perpetual cascade of cytokines post-irradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys, 33, 99-109.
31. Qi JZ, Wang FS, Zhang HW, Cao JC, Zhang TM. (2006). Chemical modification of superoxide dismutase by low molecular weight heparin and their physical and chemical properties. Chin Pharm J, 41, 150-153.
32. Schalkwijk J, van den Berg WB, van de Putte LB, Joosten LA, van den Bersselaar L. (1985). Cationization of catalase, peroxidase, and superoxide dismutase. Effect of improved intraarticular retention on experimental arthritis in mice. J Clin Invest, 76, 198-205.
33. Shibata Y, Metzger WJ, Myrvik QN. (1997). Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: Mannose receptor-mediated phagocytosis initiates IL-12 production. J Immunol, 159, 2462-2467.
34. Takagi T, Kitano M, Masuda S, Tokuda H, Takakura Y, Hashida M. (1997). Augmented inhibitory effect of superoxide dismutase on superoxide anion release from macrophages by direct cationization. Biochim Biophys Acta, 1335, 91-98.
35. Thanou M, Verhoef JC, Junginger HE.(2001). Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Del Rev, 50, S91-S101. (Pubitemid 32905357)
36. Tsubokawa T, Jadhav V, Solaroglu I, Shiokawa Y, Konishi Y, Zhang JH. (2007). Lecithinized superoxide dismutase improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Stroke, 38, 1057-1062.
37. Tyagi SC, Kumar S, Katwa L. (1997). Differential regulation of extracellular matrix metalloproteinase and tissue inhibitor by heparin and cholesterol in fibroblast cells. J Mol Cell Cardiol, 29, 391-404.
38. van den Berg WB, van de Putte LB, Zwarts WA, Joosten LA. (1984). Electrical charge of the antigen determines intraarticular antigen handling and chronicity of arthritis in mice. J Clin Invest, 74, 1850-1859.
39. van der Merwe SM, Verhoef JC, Verheijden JH, Kotzé AF, Junginger HE. (2004). Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur J Pharm Biopharm, 58, 225-235.
40. Xing R, Liu S, Guo Z, Yu H, Wang P, Li C, Li Z, Li P. (2005). Relevance of molecular weight of chitosan and its derivatives and their antioxidant activities in vitro. Bioorg Med Chem, 13, 1573-1577.
41. Xing R, Liu S, Guo Z, Yu H, Zhong Z, Ji X, Li P. (2008). Relevance of molecular weight of chitosan-N-2-hydroxypropyl trimethyl ammonium chloride and their antioxidant activities. Eur J Med Chem, 43, 336-340.
42. Yabe Y, Nishikawa M, Tamada A, Takakura Y, Hashida M. (1999). Targeted delivery and improved therapeutic potential of catalase by chemical modification: Combination with superoxide dismutase derivatives. J Pharmacol Exp Ther, 289, 1176-1184.
43. Yabe Y, Kobayashi N, Nishihashi T, Takahashi R, Nishikawa M, Takakura Y, Hashida M. (2001). Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J Pharmacol Exp Ther, 298, 894-899.
44. Zhang HW, Wang FS, Shao W, Zheng XL, Qi JZ, Cao JC, Zhang TM. (2006). Characterization and stability investigation of Cu,Znsuperoxide dismutase covalently modified by low molecular weight heparin. Biochemistry (Moscow), 71, S96-S100.
45. Zhang ZG, Zhang QZ, Cheng YN, Ji SL, Du GH. (2007). Antagonistic effects of ultra-low-molecular-weight heparin against cerebral ischemia/reperfusion injury in rats. Pharmacol Res, 56, 350-355.